COVID-19 Resources

Vaccine and Treatments

The Food & Drug Administration (FDA) has fully approved the Pfizer Bio-N-Tech COVID-19 vaccine for people 16 and older — making it the first to be fully licensed for use in the United States. We anticipate full approval for the Moderna and Johnson & Johnson (J&J) COVID-19 Vaccines for adults as soon as the FDA has conducted its final analysis. For more information, please click the button “FDA Fully Approved Pfizer-BioNTech Vaccine (Comirnaty) Information.”

The FDA has authorized a third shot of the Pfizer and Moderna vaccines as a booster shot. These shots are now available to immunocompromised people and are anticipated to be available to Pfizer and Moderna-vaccinated people eight months after the date of their second shot, beginning around September 20. The J&J vaccine data is currently being evaluated for booster shot efficacy and information on this vaccine’s booster shot will be provided when available. For more information about the booster shots, visit “Vaccine FAQ” below.